Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Natanson

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Current Opinion in Critical Care|December 24, 2004
Defining the standard of care in randomized controlled trials of titrated therapiesKatherine J Deans, Peter C Minneci, Peter Q Eichacker, et al.
Intensive Care Medicine|July 14, 2012
Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analysesChristiane S Hartog, Helga Skupin, Charles Natanson, et al.
Critical Care Medicine|January 11, 2005
The efficacy of drotrecogin alfa depends on severity of illnessKatherine J Deans, Peter C Minneci, Peter Q Eichacker, et al.
Transfusion|December 23, 2011
Transfusion of older stored blood and risk of death: a meta-analysisDong Wang, Junfeng Sun, Steven B Solomon, et al.
BMJ (Clinical Research Ed.)|November 12, 2014
Concerns over use of hydroxyethyl starch solutionsChristiane S Hartog, Charles Natanson, Junfeng Sun, et al.
Transfusion|December 13, 2012
In reply to "Transfusion of older blood and risk of death: unanswered questions"Dong Wang, Junfeng Sun, Steven B Solomon, et al.
Anesthesia and Analgesia|July 29, 2010
Walk a mile in whose shoes?Katherine J Deans, Peter Minneci, Peter Q Eichacker, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumesPeter Q Eichacker, Eric P Gerstenberger, Steven M Banks, et al.
Expert Opinion on Investigational Drugs|October 4, 2011
The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of deathPing Qiu, Xizhong Cui, Amisha Barochia, et al.
Critical Care Medicine|July 27, 2013
Antitumor necrosis factor therapy is associated with improved survival in clinical sepsis trials: a meta-analysisPing Qiu, Xizhong Cui, Junfeng Sun, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Current Opinion in Critical Care|December 24, 2004
Defining the standard of care in randomized controlled trials of titrated therapiesKatherine J Deans, Peter C Minneci, Peter Q Eichacker, et al.
Intensive Care Medicine|July 14, 2012
Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analysesChristiane S Hartog, Helga Skupin, Charles Natanson, et al.
Critical Care Medicine|January 11, 2005
The efficacy of drotrecogin alfa depends on severity of illnessKatherine J Deans, Peter C Minneci, Peter Q Eichacker, et al.
Transfusion|December 23, 2011
Transfusion of older stored blood and risk of death: a meta-analysisDong Wang, Junfeng Sun, Steven B Solomon, et al.
BMJ (Clinical Research Ed.)|November 12, 2014
Concerns over use of hydroxyethyl starch solutionsChristiane S Hartog, Charles Natanson, Junfeng Sun, et al.
Transfusion|December 13, 2012
In reply to "Transfusion of older blood and risk of death: unanswered questions"Dong Wang, Junfeng Sun, Steven B Solomon, et al.
Anesthesia and Analgesia|July 29, 2010
Walk a mile in whose shoes?Katherine J Deans, Peter Minneci, Peter Q Eichacker, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumesPeter Q Eichacker, Eric P Gerstenberger, Steven M Banks, et al.
Expert Opinion on Investigational Drugs|October 4, 2011
The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of deathPing Qiu, Xizhong Cui, Amisha Barochia, et al.
Critical Care Medicine|July 27, 2013
Antitumor necrosis factor therapy is associated with improved survival in clinical sepsis trials: a meta-analysisPing Qiu, Xizhong Cui, Junfeng Sun, et al.
Pageof 12